clenbuterol has been researched along with Myocardial Ischemia in 2 studies
Clenbuterol: A substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma.
clenbuterol : A substituted aniline that is 2,6-dichloroaniline in which the hydrogen at position 4 has been replaced by a 2-(tert-butylamino)-1-hydroxyethyl group.
Myocardial Ischemia: A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Two male bodybuilders, ages 18 and 22 years, presented to the Emergency Department with palpitations, nausea, vomiting, chest pain, diaphoresis, and tachycardia shortly after ingesting clenbuterol." | 7.79 | Myocardial ischemia associated with clenbuterol abuse: report of two cases. ( Huckins, DS; Lemons, MF, 2013) |
| "Two male bodybuilders, ages 18 and 22 years, presented to the Emergency Department with palpitations, nausea, vomiting, chest pain, diaphoresis, and tachycardia shortly after ingesting clenbuterol." | 3.79 | Myocardial ischemia associated with clenbuterol abuse: report of two cases. ( Huckins, DS; Lemons, MF, 2013) |
| "Clenbuterol is a potent beta-2 agonist widely misused by professional athletes and bodybuilders." | 3.01 | Adverse events of clenbuterol among athletes: a systematic review of case reports and case series. ( Kumari, S; Pal, B; Prabhakar, PK; Sahu, SK; Tewari, D, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kumari, S | 1 |
| Pal, B | 1 |
| Sahu, SK | 1 |
| Prabhakar, PK | 1 |
| Tewari, D | 1 |
| Huckins, DS | 1 |
| Lemons, MF | 1 |
1 review available for clenbuterol and Myocardial Ischemia
| Article | Year |
|---|---|
Adverse events of clenbuterol among athletes: a systematic review of case reports and case series.
Topics: Adrenergic beta-Agonists; Cardiomyopathies; Clenbuterol; Humans; Myocardial Infarction; Myocardial I | 2023 |
1 other study available for clenbuterol and Myocardial Ischemia
| Article | Year |
|---|---|
Myocardial ischemia associated with clenbuterol abuse: report of two cases.
Topics: Adolescent; Adrenergic beta-Agonists; Chest Pain; Clenbuterol; Doping in Sports; Humans; Male; Myoca | 2013 |